Literature DB >> 35014105

Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future.

Francesca M Manzella1,2, Douglas F Covey3,4, Vesna Jevtovic-Todorovic1, Slobodan M Todorovic1,2.   

Abstract

Since the 1990s, there has been waning interest in researching general anaesthetics (anaesthetics). Although currently used anaesthetics are mostly safe and effective, they are not without fault. In paediatric populations and neonatal animal models, they are associated with learning impairments and neurotoxicity. In an effort to research safer anaesthetics, we have gone back to re-examine neuroactive steroids as anaesthetics. Neuroactive steroids are steroids that have direct, local effects in the central nervous system. Since the discovery of their anaesthetic effects, neuroactive steroids have been consistently used in human or veterinary clinics as preferred anaesthetic agents. Although briefly abandoned for clinical use due to unwanted vehicle side effects, there has since been renewed interest in their therapeutic value. Neuroactive steroids are safe sedative/hypnotic and anaesthetic agents across various animal species. Importantly, unlike traditional anaesthetics, they do not cause extensive neurotoxicity in the developing rodent brain. Similar to traditional anaesthetics, neuroactive steroids are modulators of synaptic and extrasynaptic γ-aminobutyric acid type A (GABAA ) receptors and their interactions at the GABAA receptor are stereo- and enantioselective. Recent work has also shown that these agents act on other ion channels, such as high- and low-voltage-activated calcium channels. Through these mechanisms of action, neuroactive steroids modulate neuronal excitability, which results in characteristic burst suppression of the electroencephalogram, and a surgical plane of anaesthesia. However, in addition to their interactions with voltage and ligand gated ions channels, neuroactive steroids interact with membrane bound metabotropic receptors and xenobiotic receptors to facilitate signaling of prosurvival, antiapoptotic pathways. These pathways play a role in their neuroprotective effects in neuronal injury and may also prevent extensive apoptosis in the developing brain during anaesthesia. The current review explores the history of neuroactive steroids as anaesthetics in humans and animal models, their diverse mechanisms of action, and their neuroprotective properties.
© 2021 British Society for Neuroendocrinology.

Entities:  

Keywords:  GABAA receptors; T-channels; anaesthesia; neuroactive steroids; neuroprotection

Mesh:

Substances:

Year:  2022        PMID: 35014105      PMCID: PMC8866223          DOI: 10.1111/jne.13086

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  160 in total

1.  Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity.

Authors:  Jessie I Luoma; Brooke G Kelley; Paul G Mermelstein
Journal:  Steroids       Date:  2011-03-01       Impact factor: 2.668

2.  A preliminary clinical study of CT1341--a steroid anaesthetic agent.

Authors:  D Campbell; A C Forrester; D C Miller; I Hutton; J A Kennedy; T D Lawrie; A R Lorimer; D McCall
Journal:  Br J Anaesth       Date:  1971-01       Impact factor: 9.166

3.  Alpha 1 subunit-containing GABA type A receptors in forebrain contribute to the effect of inhaled anesthetics on conditioned fear.

Authors:  James M Sonner; Mike Cascio; Yilei Xing; Michael S Fanselow; Jason E Kralic; A Leslie Morrow; Esa R Korpi; Steven Hardy; Brian Sloat; Edmond I Eger; Gregg E Homanics
Journal:  Mol Pharmacol       Date:  2005-04-15       Impact factor: 4.436

4.  Modulation of GABAA receptor activity by alphaxalone.

Authors:  G A Cottrell; J J Lambert; J A Peters
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

5.  Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes.

Authors:  R H Purdy; A L Morrow; J R Blinn; S M Paul
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

Review 6.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species.

Authors:  Bridgette D Semple; Klas Blomgren; Kayleen Gimlin; Donna M Ferriero; Linda J Noble-Haeusslein
Journal:  Prog Neurobiol       Date:  2013-04-11       Impact factor: 11.685

7.  Estrogen-mediated neuroprotection after experimental stroke in male rats.

Authors:  T J Toung; R J Traystman; P D Hurn
Journal:  Stroke       Date:  1998-08       Impact factor: 7.914

8.  Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

Authors:  N Brown; J Kerby; T P Bonnert; P J Whiting; K A Wafford
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 9.  GABA A receptors: subtypes provide diversity of function and pharmacology.

Authors:  Richard W Olsen; Werner Sieghart
Journal:  Neuropharmacology       Date:  2008-08-08       Impact factor: 5.250

10.  Effects of alfaxalone on cerebral blood flow and intrinsic neural activity of rhesus monkeys: A comparison study with ketamine.

Authors:  Chun-Xia Li; Doty Kempf; Leonard Howell; Xiaodong Zhang
Journal:  Magn Reson Imaging       Date:  2020-10-27       Impact factor: 2.546

View more
  1 in total

Review 1.  General Anesthesia and the Young Brain: The Importance of Novel Strategies with Alternate Mechanisms of Action.

Authors:  Stefan Maksimovic; Nemanja Useinovic; Nidia Quillinan; Douglas F Covey; Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Int J Mol Sci       Date:  2022-02-08       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.